Published in J Cell Mol Med on September 01, 2012
N,N-dimethylacetamide regulates the proinflammatory response associated with endotoxin and prevents preterm birth. Am J Pathol (2013) 1.43
A Review of the Pharmacological Effects of the Dried Root of Polygonum cuspidatum (Hu Zhang) and Its Constituents. Evid Based Complement Alternat Med (2013) 0.89
Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients. J Cell Mol Med (2014) 0.81
Urantide improves atherosclerosis by controlling C-reactive protein, monocyte chemotactic protein-1 and transforming growth factor-β expression in rats. Exp Ther Med (2014) 0.79
Ox-LDL Upregulates IL-6 Expression by Enhancing NF-κB in an IGF2-Dependent Manner in THP-1 Macrophages. Inflammation (2015) 0.79
Antiatherosclerotic effect of korean red ginseng extract involves regulator of g-protein signaling 5. Evid Based Complement Alternat Med (2014) 0.79
Lipid regulators during atherogenesis: expression of LXR, PPAR, and SREBP mRNA in the human aorta. PLoS One (2013) 0.78
Combined treatment of hydroxytyrosol with carbon monoxide-releasing molecule-2 prevents TNF α-induced vascular endothelial cell dysfunction through NO production with subsequent NFκB inactivation. Biomed Res Int (2013) 0.77
Protective effects of isorhamnetin on apoptosis and inflammation in TNF-α-induced HUVECs injury. Int J Clin Exp Pathol (2015) 0.77
Cardiovascular disease and type 2 diabetes in evolutionary perspective: a critical role for helminths? Evol Med Public Health (2016) 0.76
Notoginsenoside R1 attenuates atherosclerotic lesions in ApoE deficient mouse model. PLoS One (2014) 0.76
The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease. Front Pharmacol (2017) 0.75
Macrophage-mediated response to hypoxia in disease. Hypoxia (Auckl) (2014) 0.75
Lipid Droplet Biogenesis and Function in the Endothelium. Circ Res (2017) 0.75
Hyperglycemia Determines Increased Specific MicroRNAs Levels in Sera and HDL of Acute Coronary Syndrome Patients and Stimulates MicroRNAs Production in Human Macrophages. PLoS One (2016) 0.75
P-Selectin Targeted Dexamethasone-Loaded Lipid Nanoemulsions: A Novel Therapy to Reduce Vascular Inflammation. Mediators Inflamm (2016) 0.75
Correlation of lifetime progress of atherosclerosis and morphologic markers of severity in humans: new tools for a more sensitive evaluation. Clinics (Sao Paulo) (2012) 0.75
Regulation of indoleamine 2,3-dioxygenase in primary human saphenous vein endothelial cells. J Inflamm Res (2015) 0.75
Loss of ADAMTS4 reduces high fat diet-induced atherosclerosis and enhances plaque stability in ApoE(-/-) mice. Sci Rep (2016) 0.75
Total and differential white blood cell counts in late life predict 8-year incident stroke: the Honolulu Heart Program. J Am Geriatr Soc (2015) 0.75
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36
Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol (2000) 14.59
The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol (2006) 9.61
Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res (2006) 8.26
Nomenclature of monocytes and dendritic cells in blood. Blood (2010) 6.63
The immune system in atherosclerosis. Nat Immunol (2011) 6.51
Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol (2009) 6.11
Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol (2009) 5.28
Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol (2007) 4.62
Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med (2002) 4.25
Platelets in inflammation and atherogenesis. J Clin Invest (2005) 4.10
Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol (2008) 3.79
Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci (2000) 3.70
A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol (2004) 3.66
Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol (2010) 3.53
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet (1997) 3.40
Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol (2003) 3.35
The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci U S A (2000) 3.32
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation (2004) 3.30
Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol (2009) 3.09
Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol (2009) 3.05
Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res (2010) 3.03
Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol (2009) 2.80
Coexisting proinflammatory and antioxidative endothelial transcription profiles in a disturbed flow region of the adult porcine aorta. Proc Natl Acad Sci U S A (2004) 2.79
Translating molecular discoveries into new therapies for atherosclerosis. Nature (2008) 2.67
Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol (2006) 2.67
Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest (2002) 2.58
IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest (2004) 2.56
Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol (2008) 2.17
Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res (2005) 2.15
Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med (2009) 2.15
Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol (2000) 2.12
CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost (2004) 2.09
Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol (2010) 2.07
Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol (2011) 1.98
Chronic endoplasmic reticulum stress activates unfolded protein response in arterial endothelium in regions of susceptibility to atherosclerosis. Circ Res (2009) 1.97
C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol (2006) 1.96
Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol (2003) 1.80
The LDL modification hypothesis of atherogenesis: an update. J Lipid Res (2008) 1.66
Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2. Circ Res (2007) 1.63
The potential role of resistin in atherogenesis. Atherosclerosis (2005) 1.62
Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation. Blood (2004) 1.56
Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS One (2007) 1.51
Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol (2004) 1.51
Thematic review series: The immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease. J Lipid Res (2005) 1.46
The vascular biology of atherosclerosis and imaging targets. J Nucl Med (2010) 1.45
Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. Am J Pathol (1986) 1.45
Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler Thromb Vasc Biol (2006) 1.44
Therapeutic targeting of chemokine interactions in atherosclerosis. Nat Rev Drug Discov (2010) 1.38
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. Eur Heart J (2009) 1.36
Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives. Atherosclerosis (2009) 1.34
Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells. J Biol Chem (2001) 1.33
Localization of unesterified cholesterol in human atherosclerotic lesions. Demonstration of filipin-positive, oil-red-O-negative particles. Am J Pathol (1984) 1.30
The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression. Circ Res (2010) 1.29
Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler Thromb Vasc Biol (2010) 1.23
Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res (2001) 1.22
Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. Med Res Rev (2008) 1.21
Shear stress activation of SREBP1 in endothelial cells is mediated by integrins. Arterioscler Thromb Vasc Biol (2002) 1.20
Dendritic cells in atherosclerotic disease. Clin Immunol (2009) 1.17
Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis. J Lipid Res (2008) 1.16
New observations on the trafficking and diapedesis of monocytes. Curr Opin Hematol (2010) 1.13
P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem (2006) 1.13
Circulating oxidized LDL: a biomarker and a pathogenic factor. Curr Opin Lipidol (2009) 1.12
Fine-tuning leukocyte responses: towards a chemokine 'interactome'. Trends Immunol (2006) 1.12
Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol (1995) 1.11
PECAM-1 is a critical mediator of atherosclerosis. Dis Model Mech (2008) 1.09
Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro. Arterioscler Thromb Vasc Biol (2007) 1.07
Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study. Atherosclerosis (2002) 1.07
Macrophages heterogeneity in atherosclerosis - implications for therapy. J Cell Mol Med (2010) 1.05
Soluble N-cadherin overexpression reduces features of atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol (2008) 1.04
Distinctive expression of chemokines and transforming growth factor-beta signaling in human arterial endothelium during atherosclerosis. Am J Pathol (2007) 1.03
The role of mast cells in atherosclerosis. Int Arch Allergy Immunol (1997) 1.03
The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment. FASEB J (2005) 1.02
Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway. Circ Res (2007) 1.02
Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNFalpha-NFkappaB-dependent manner. J Biol Chem (2007) 0.99
Suppression of inflammatory signaling in monocytes from patients with coronary artery disease. J Mol Cell Cardiol (2008) 0.98
Neutrophils launch monocyte extravasation by release of granule proteins. Thromb Haemost (2009) 0.98
Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A. Arterioscler Thromb Vasc Biol (2005) 0.98
Comparison of vascular smooth muscle cell apoptosis and fibrous cap morphology in symptomatic and asymptomatic carotid artery disease. Ann Vasc Surg (2003) 0.98
Endothelial transcriptome profiles in vivo in complex arterial flow fields. Ann Biomed Eng (2007) 0.96
Metalloproteinases in development and progression of vascular disease. Pathophysiol Haemost Thromb (2005) 0.95
Importance of junctional adhesion molecule-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice. Arterioscler Thromb Vasc Biol (2005) 0.93
Endothelial heterogeneity associated with regional athero-susceptibility and adaptation to disturbed blood flow in vivo. Semin Thromb Hemost (2010) 0.93
Differential associations between soluble cellular adhesion molecules and atherosclerosis in the Dallas Heart Study: a distinct role for soluble endothelial cell-selective adhesion molecule. Arterioscler Thromb Vasc Biol (2009) 0.91
Dyslipidaemia in rheumatological autoimmune diseases. Open Cardiovasc Med J (2011) 0.90
Nuclear factor of activated T cells mediates oxidised LDL-induced calcification of vascular smooth muscle cells. Diabetologia (2011) 0.90
Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism. Circulation (2011) 0.89
An integrated approach for the mechanisms responsible for atherosclerotic plaque regression. Exp Clin Cardiol (2011) 0.88
Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production. Am J Physiol Heart Circ Physiol (2009) 0.88
Immunoliposomes directed toward VCAM-1 interact specifically with activated endothelial cells--a potential tool for specific drug delivery. Pharm Res (2005) 0.88
Effect of depletion of monocytes/macrophages on early aortic valve lesion in experimental hyperlipidemia. Cell Tissue Res (2009) 0.85
Endothelial CD81 is a marker of early human atherosclerotic plaques and facilitates monocyte adhesion. Cardiovasc Res (2008) 0.85
A comparative study of neovascularisation in atherosclerotic plaques using CD31, CD105 and TGF beta 1. Pathobiology (2006) 0.85
Mast cells in atherogenesis: actions and reactions. Curr Atheroscler Rep (2009) 0.84
Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome. Tex Heart Inst J (2009) 0.84
Topology of protease activities reflects atherothrombotic plaque complexity. Atherosclerosis (2006) 0.84
Pathology of atherosclerosis and stenting. Neuroimaging Clin N Am (2007) 0.83
Intimal thickenings of human aorta contain modified reassembled lipoproteins. Atherosclerosis (1995) 0.83
Vascular endothelium in atherosclerosis. Cell Tissue Res (2008) 1.53
Factors secreted by mesenchymal stem cells and endothelial progenitor cells have complementary effects on angiogenesis in vitro. Stem Cells Dev (2012) 1.26
Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol (2009) 1.20
Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. Biochem Biophys Res Commun (2010) 1.18
AP-1-dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells: role of p22phox subunit. Arterioscler Thromb Vasc Biol (2008) 1.08
Monocyte chemoattractant protein-1--a major contributor to the inflammatory process associated with diabetes. Arch Physiol Biochem (2006) 1.04
Promoting effect of 5-azacytidine on the myogenic differentiation of bone marrow stromal cells. Eur J Cell Biol (2007) 0.97
Inflammatory signaling pathways regulating ApoE gene expression in macrophages. J Biol Chem (2007) 0.95
Nox enzymes and oxidative stress in atherosclerosis. Front Biosci (Schol Ed) (2012) 0.92
Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules. Biochim Biophys Acta (2011) 0.90
Increased uptake of folate conjugates by activated macrophages in experimental hyperlipemia. Cell Tissue Res (2005) 0.89
High glucose conditions induce upregulation of fractalkine and monocyte chemotactic protein-1 in human smooth muscle cells. Thromb Haemost (2008) 0.89
Designing of 'intelligent' liposomes for efficient delivery of drugs. J Cell Mol Med (2003) 0.89
Similar effects of resistin and high glucose on P-selectin and fractalkine expression and monocyte adhesion in human endothelial cells. Biochem Biophys Res Commun (2009) 0.88
Immunoliposomes directed toward VCAM-1 interact specifically with activated endothelial cells--a potential tool for specific drug delivery. Pharm Res (2005) 0.88
Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells. Vascul Pharmacol (2006) 0.87
Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose. Biochem Biophys Res Commun (2009) 0.87
Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress. J Cell Mol Med (2010) 0.87
Modified low density lipoproteins decrease the activity and expression of lysosomal acid lipase in human endothelial and smooth muscle cells. Cell Biochem Biophys (2011) 0.86
Effect of depletion of monocytes/macrophages on early aortic valve lesion in experimental hyperlipidemia. Cell Tissue Res (2009) 0.85
Aspirin rectifies calcium homeostasis, decreases reactive oxygen species, and increases NO production in high glucose-exposed human endothelial cells. J Diabetes Complications (2004) 0.85
Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways. Cell Tissue Res (2012) 0.85
A novel pro-inflammatory mechanism of action of resistin in human endothelial cells: up-regulation of SOCS3 expression through STAT3 activation. Biochem Biophys Res Commun (2012) 0.84
Osteoblast ontogeny and implications for bone pathology: an overview. Cell Tissue Res (2013) 0.83
Remote transplantation of mesenchymal stem cells protects the heart against ischemia-reperfusion injury. Stem Cells (2014) 0.83
Relationship of eNOS gene variants to diseases that have in common an endothelial cell dysfunction. J Cell Mol Med (2005) 0.83
Direct contact of umbilical cord blood endothelial progenitors with living cardiac tissue is a requirement for vascular tube-like structures formation. J Cell Mol Med (2011) 0.83
High-glucose-increased expression and activation of NADPH oxidase in human vascular smooth muscle cells is mediated by 4-hydroxynonenal-activated PPARα and PPARβ/δ. Cell Tissue Res (2015) 0.83
Neonatal Fc receptors discriminates and monitors the pathway of native and modified immunoglobulin G in placental endothelial cells. Hum Immunol (2004) 0.82
Enoxaparin reduces H2O2-induced activation of human endothelial cells by a mechanism involving cell adhesion molecules and nuclear transcription factors. Pharmacology (2007) 0.81
Expression of functionally phagocyte-type NAD(P)H oxidase in pericytes: effect of angiotensin II and high glucose. Biol Cell (2005) 0.81
Cellular mechanisms and signalling pathways activated by high glucose and AGE-albumin in the aortic endothelium. Arch Physiol Biochem (2006) 0.80
Effect of enoxaparin on high glucose-induced activation of endothelial cells. Eur J Pharmacol (2003) 0.80
High glucose induces enhanced expression of resistin in human U937 monocyte-like cell line by MAPK- and NF-kB-dependent mechanisms; the modulating effect of insulin. Cell Tissue Res (2010) 0.80
Macrophage-specific up-regulation of apolipoprotein E gene expression by STAT1 is achieved via long range genomic interactions. J Biol Chem (2011) 0.79
Upregulation of caveolin-1 expression is associated with structural modifications of endothelial cells in diabetic lung. Microvasc Res (2010) 0.79
Summary statement IV: Obesity and diabetes: opportunities for translation of basic research. Vascul Pharmacol (2006) 0.79
Resistin up-regulates fractalkine expression in human endothelial cells: lack of additive effect with TNF-alpha. Biochem Biophys Res Commun (2009) 0.79
Heparin-anthranoid conjugates associated with nanomagnetite particles and their cytotoxic effect on cancer cells. J Biomed Nanotechnol (2014) 0.78
Enoxaparin--a low molecular weight heparin, restores the altered vascular reactivity of resistance arteries in aged and aged-diabetic hamsters. Vascul Pharmacol (2003) 0.78
Cellular dysfunction in inflammatory-related vascular disorders' review series. The inflammatory process: a new dimension of a 19 century old story. J Cell Mol Med (2009) 0.76
Binding and uptake of transferrin-bound liposomes targeted to transferrin receptors of endothelial cells. Vascul Pharmacol (2002) 0.76
Homozygous familial hypercholesterolemia: specific indication for domino liver transplantation. Transplantation (2003) 0.76
Superoxide dismutase entrapped-liposomes restore the impaired endothelium-dependent relaxation of resistance arteries in experimental diabetes. Eur J Pharmacol (2004) 0.76
Growth factors in orthopedic surgery. J Med Life (2010) 0.75
Testosterone stimulates proliferation and preserves stemness of human adult mesenchymal stem cells and endothelial progenitor cells. Rom J Morphol Embryol (2016) 0.75
Functional analysis of the fractalkine gene promoter in human aortic smooth muscle cells exposed to proinflammatory conditions. FEBS J (2014) 0.75